Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Inactivation of Soluble Guanylate Cyclase by Stoichiometric S-Nitrosation

Bernd Mayer, Andrei L. Kleschyov, Heike Stessel, Michael Russwurm, Thomas Münzel, Doris Koesling and Kurt Schmidt
Molecular Pharmacology April 2009, 75 (4) 886-891; DOI: https://doi.org/10.1124/mol.108.052142
Bernd Mayer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrei L. Kleschyov
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heike Stessel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Russwurm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Münzel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Doris Koesling
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kurt Schmidt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Dysfunction of vascular nitric oxide (NO)/cGMP signaling is believed to contribute essentially to various cardiovascular disorders. Besides synthesis and/or bioavailability of endothelial NO, impaired function of soluble guanylate cyclase (sGC) may play a key role in vascular dysfunction. Based on the proposal that desensitization of sGC through S-nitrosation contributes to vascular NO resistance (

Proc Natl Acad Sci U S A:-12317, 2007

), we exposed purified sGC to dinitrosyl iron complexes (DNICs), known as potent nitrosating agents. In the presence of 2 mM GSH, DNICs stimulated cGMP formation with EC50 values of 0.1 to 0.5 μM and with an efficacy of 70 to 80% of maximal activity measured with 10 μM 2,2-diethyl-1-nitroso-oxyhydrazine (DEA/NO). In the absence of GSH, the efficacy of DNICs was markedly reduced, and sGC stimulation was counteracted by the inhibition of both basal and DEA/NO-stimulated cGMP formation at higher DNIC concentrations. Inactivation of sGC was slowly reversed in the presence of 2 mM GSH and associated with stoichiometric S-nitrosation of the protein (2.05 ± 0.18 mol S-nitrosothiol per mol of 143-kDa heterodimer). S-Nitrosoglutathione and sodium nitroprusside caused partial inhibition of DEA/NO-stimulated sGC that was prevented by GSH, whereas nitroglycerin (0.3 mM) had no effect. Our findings indicate that nitrosation of two cysteine residues in sGC heterodimers results in enzyme inactivation. Protection by physiologically relevant concentrations of GSH (10 μM to 3 mM) suggests that S-nitrosation of sGC may contribute to vascular dysfunction in inflammatory disorders associated with nitrosative and oxidative stress and GSH depletion.

Footnotes

  • This work was supported by the Fonds zur Föderung der Wissenschaftlichen Forschung in Austria [Grant P20669]; the Deutsche Forschungsgemeinschaft [Grant KO1157/4-1]; the European Vascular Genomic Network [Grant LSHM-CT-2003-503254]; and the Forschungsvereinigungen “Otto von Guericke” [Grant PRO INNO II: KF0193301RK5].

  • ABBREVIATIONS: sGC, soluble guanylate cyclase; BSA, bovine serum albumin; DEA/NO, 2,2-diethyl-1-nitroso-oxyhydrazine; DNIC, dinitrosyl iron complex; GSNO, S-nitrosoglutathione; GTN, glyceroltrinitrate (nitroglycerin); PBS, phosphate-buffered saline; SNP, sodium nitroprusside; TEA, triethanolamine; YC-1, 3-(5′-hydroxymethyl-2′-furyl)-1-benzylindazole; RSNO, S-nitrosothiol.

    • Received September 18, 2008.
    • Accepted December 23, 2008.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 75 (4)
Molecular Pharmacology
Vol. 75, Issue 4
1 Apr 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Inactivation of Soluble Guanylate Cyclase by Stoichiometric S-Nitrosation
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Inactivation of Soluble Guanylate Cyclase by Stoichiometric S-Nitrosation

Bernd Mayer, Andrei L. Kleschyov, Heike Stessel, Michael Russwurm, Thomas Münzel, Doris Koesling and Kurt Schmidt
Molecular Pharmacology April 1, 2009, 75 (4) 886-891; DOI: https://doi.org/10.1124/mol.108.052142

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Inactivation of Soluble Guanylate Cyclase by Stoichiometric S-Nitrosation

Bernd Mayer, Andrei L. Kleschyov, Heike Stessel, Michael Russwurm, Thomas Münzel, Doris Koesling and Kurt Schmidt
Molecular Pharmacology April 1, 2009, 75 (4) 886-891; DOI: https://doi.org/10.1124/mol.108.052142
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Analgesic Effects and Mechanisms of Licochalcones
  • Induced Fit Ligand Binding to CYP3A4
  • Englerin A Inhibits T-Type Channels
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics